Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T14:52:53.199Z.
Calculation as of: 2026-10-06T14:52:53.199Z.
Quote observation: 2026-10-06T14:45:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f6adff8253f4c85dc5eb0f5c76b7f284768243a99251a0912c87940a98678e1d
EARNINGS YIELD
N/A
Market Cap
$10.06M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.00M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.92M
Earnings Yield
N/A
TTM Avg
32.42%
3Y Avg
32.42%
5Y Avg
32.42%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lifeward Ltd. (LFWD) | $10.47M | N/A | N/A | N/A | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.42M | N/A | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.09M | N/A | N/A | N/A | N/A |
| MetaVia Inc. (MTVA)vs › | $10.08M | N/A | N/A | N/A | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | N/A | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $10.98M | N/A | N/A | N/A | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.00M | N/A | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $11.01M | N/A | N/A | N/A | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.92M | N/A | 32.42% | 32.42% | 32.42% |
| Biofrontera Inc. (BFRI)vs › | $11.13M | N/A | 10.43% | 10.43% | 10.43% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute